SG11201805821UA - Stable and palatable composition of vitamin c and zinc lozenge tablets - Google Patents

Stable and palatable composition of vitamin c and zinc lozenge tablets

Info

Publication number
SG11201805821UA
SG11201805821UA SG11201805821UA SG11201805821UA SG11201805821UA SG 11201805821U A SG11201805821U A SG 11201805821UA SG 11201805821U A SG11201805821U A SG 11201805821UA SG 11201805821U A SG11201805821U A SG 11201805821UA SG 11201805821U A SG11201805821U A SG 11201805821UA
Authority
SG
Singapore
Prior art keywords
international
vitamin
zinc
city
pct
Prior art date
Application number
SG11201805821UA
Inventor
Wendell G Mendoza
Rita Josefina M Santos
Original Assignee
Novex Science Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novex Science Pte Ltd filed Critical Novex Science Pte Ltd
Publication of SG11201805821UA publication Critical patent/SG11201805821UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property -, Organization 11111111011110111010101111101011111011101110111101101011111001111101111011111 International Bureau .. .... ..Yejd (10) International Publication Number (43) International Publication Date ..... ...r .....1 WO 2017/123103 Al 20 July 2017 (20.07.2017) WIPO I PCT (51) (21) (22) (25) Filing Language: (26) Publication Language: (71) (72) (71) (74) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, A61K 9/20 (2006.01) A61K 31/375 (2006.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, A61K 47/26 (2006.01) A61K 33/30 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, International Application Number: KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, PCT/PH2016/000001 MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, International Filing Date: PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, 15 January 2016 (15.01.2016) SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. English (84) Designated States (unless otherwise indicated, for every English kind of regional protection available): ARIPO (BW, GH, Applicant: DEE, Kennie U. [PH/PH]; 59D 12th Street GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, corner Gilmore Avenue, New Manila, Quezon City, 1102 TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, (PH). TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, Inventors; and LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, Applicants : MENDOZA, Wendell G. [PH/PH]; 66 SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, United Street, Mandaluyong City, 1550 (PH). SANTOS, GW, KM, ML, MR, NE, SN, TD, TG). Rita Josefina M.; 5 Andres Malong, Project 4, Quezon City, 1109 (PH). Declarations under Rule 4.17: Common Representative: DEE, Kennie U.; 59D 12th of inventorship (Rule 4.17(iv)) Street corner Gilmore Avenue, New Manila, Quezon City, Published: 1102 (PH). — with international search report (Art. 21(3)) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, (81) — _ = — = Title: STABLE AND PALATABLE COMPOSITION OF VITAMIN C AND ZINC LOZENGE TABLETS 10 = Figure 1 —4—Zinc Citrate --Zinc Oxide = (54) . = = = = = ti 6 2 gi = , q 4 '. '5' 2 0 : The present invention at high concentration and — — 11 en © 11 M ei 11 IN 1-1 (57) 0 present ei 0 10 20 30 40 50 60 70 80 90 100 %Vitamin C from Sodium Ascorbate relates to palatable lozenge tablets containing vitamin C and zinc, wherein the vitamin C is is stable against oxidation and formation of carbon dioxide. 0
SG11201805821UA 2016-01-15 2016-01-15 Stable and palatable composition of vitamin c and zinc lozenge tablets SG11201805821UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/PH2016/000001 WO2017123103A1 (en) 2016-01-15 2016-01-15 Stable and palatable composition of vitamin c and zinc lozenge tablets

Publications (1)

Publication Number Publication Date
SG11201805821UA true SG11201805821UA (en) 2018-08-30

Family

ID=59311387

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201805821UA SG11201805821UA (en) 2016-01-15 2016-01-15 Stable and palatable composition of vitamin c and zinc lozenge tablets

Country Status (9)

Country Link
KR (1) KR20180101530A (en)
CN (1) CN108495621A (en)
AU (1) AU2016386385B2 (en)
BR (1) BR112018013689A2 (en)
HK (1) HK1256968A1 (en)
NZ (1) NZ744260A (en)
PH (1) PH12018501438A1 (en)
SG (1) SG11201805821UA (en)
WO (1) WO2017123103A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108347990A (en) * 2015-10-16 2018-07-31 诺维克斯科学私人有限公司 The stabilization composition of vitamin C and zinc metal sheet agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316008B1 (en) * 1998-09-03 2001-11-13 John C. Godfrey Combination of zinc ions and vitamin C and method of making
FR2883182B1 (en) * 2005-03-16 2008-02-15 Novartis Ag VITAMIN COMPOSITION USEFUL IN THE TREATMENT OF OCULAR DISEASES
WO2006130027A1 (en) * 2005-05-31 2006-12-07 Santos Ma Joyce Bedelia B Aqueous oral liquid vitamin supplements containing stabilized vitamin c and metal ions
US8491937B2 (en) 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
WO2010077878A1 (en) * 2008-12-15 2010-07-08 Fleming And Company, Pharmaceuticals Rapidly dissolving vitamin formulation and methods of using the same

Also Published As

Publication number Publication date
CN108495621A (en) 2018-09-04
WO2017123103A1 (en) 2017-07-20
BR112018013689A2 (en) 2019-04-30
NZ744260A (en) 2020-07-31
HK1256968A1 (en) 2019-10-04
KR20180101530A (en) 2018-09-12
WO2017123103A8 (en) 2018-07-26
AU2016386385B2 (en) 2020-05-21
AU2016386385A1 (en) 2018-07-26
PH12018501438A1 (en) 2018-11-05

Similar Documents

Publication Publication Date Title
SG11201804901WA (en) Compounds for the treatment of cancer and inflammatory disease
SG11201810116VA (en) Exosomes comprising therapeutic polypeptides
SG11201407534PA (en) New diazaspirocycloalkane and azaspirocycloalkane
SG11201408318RA (en) Compositions and methods for transmucosal absorption
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201903076QA (en) Carbamoyl phenylalaninol compounds and uses therof
SG11201810352XA (en) New antibacterial compounds
SG11201900486WA (en) Treatment and prevention of sleep disorders
SG11201806480UA (en) Derivatives of pyrroloimidazole or analogues thereof which are useful for the treatment of inter alia cancer
SG11201408641UA (en) Phenoxyethyl piperidine compounds
SG11201805204WA (en) Nicotine particle capsule
SG11201408240TA (en) Treatment of motor and movement disorder side effects associated with parkinson's disease treatments
SG11201811351WA (en) Compositions and methods for forming stable, liquid metal oxide/hydroxide formulations
SG11201804220SA (en) Activated stem cells and systemic treatment methods for infected wounds
SG11201407536UA (en) Topical pharmaceutical compositions comprising terbinafine and urea
SG11201804587QA (en) Isoindole compounds
SG11201408509PA (en) Racecadotril lipid compositions
SG11201810934TA (en) Microparticles comprising a sulphur-containing compound
SG11201803816RA (en) Targeting of the formyl-peptide receptor 2/lipoxin a4 receptor (fpr2/alx) for treatment of heart disease
SG11201810192TA (en) Antibacterial compositions
SG11201806424TA (en) Therapeutic compounds
SG11201807023QA (en) Compositions and methods for preventing and/or treating vitamin b12 deficiency
SG11201907950VA (en) Complexes for treating sensitivity
SG11201809494VA (en) Pharmaceutical composition comprising eteplirsen